Recombinant cell-based bioluminescence assay for androgen bioactivity determination in clinical samples

Clinical Chemistry

Volumn 51, Issue 10, 2005, Pages 1995-1998

  Michelini, Elisa ^a,b   Magliulo, Maria ^a   Leskinen, Piia ^c   Virta, Marko ^c   Karp, Matti ^c,d   Roda, Aldo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF TURKU   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; ESTROGEN DERIVATIVE; GLUCOCORTICOID RECEPTOR; LUCIFERASE; PLASMID VECTOR; PROGESTERONE RECEPTOR; TESTOSTERONE;

ANALYTIC METHOD; BIOLUMINESCENCE; BLOOD ANALYSIS; CONFERENCE PAPER; CULTURE MEDIUM; DRUG ACTIVITY; FUNGAL STRAIN; FUNGUS CULTURE; GENETIC ENGINEERING; HORMONE DETERMINATION; HUMAN; IC 50; LABORATORY TEST; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SACCHAROMYCES CEREVISIAE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TECHNIQUE;

ANDROGENS; BIOLOGICAL ASSAY; HUMANS; LUMINESCENT MEASUREMENTS; ORGANISMS, GENETICALLY MODIFIED; RECEPTORS, ANDROGEN; REPRODUCIBILITY OF RESULTS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 25444452108     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.053017     Document Type: Conference Paper

References (16)

1. Kemppainen JA, Lane MV, Sar M, Wilson EM. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 1992;267:968-74.
2. Lin B, White JT, Lu W, Xie T, Utleg AG, Yan X, et al. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res 2005;65: 3081-91.
3. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, et al. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 1997;143:205-12.
4. Lathers CM. Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment [Review]. J Clin Pharmacol 2002;42:7-23.
5. Hutchinson TH, Brown R, Brugger KE, Campbell PM, Holt M, Lange R, et al. Ecological risk assessment of endocrine disruptors [Review]. Environ Health Perspect 2000;108:1007-14.
6. Lee HJ, Lee YS, Kwon HB, Lee K. Novel yeast bioassay for detection of androgenic and antiandrogenic compounds. Toxicol In Vitro 2003;17:237-44.
7. Raivio T, Palvimo JJ, Dunkel L, Wickman S, Janne OA. Novel assay for determination of androgen bioactivity in human serum. J Clin Endocrinol Metab 2001;86:1539-44.
8. Bricout V, Wright F. Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? [Review]. Eur J Appl Physiol 2004;92: 1-12.
9. Michelini E, Leskinen P, Virta M, Karp M, Roda A. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Biosens Bioelectron 2005;20:2261-7.
10. Leskinen P, Virta M, Karp M. One-step measurement of firefly luciferase activity in yeast. Yeast 2003;20:1109-13.
11. Leskinen P, Michelini E, Picard D, Karp M, Virta M. Bioluminescent yeast assays for detecting estrogenic and androgenic activity in different matrices. Chemosphere;in press (dx.doi.org/10.1016/j.chemosphere. 2005.01.080).
12. Yen S, Miyamoto H, Chang C. Hydroxyflutamide may not always be a pure antiandrogen. Lancet 1997;349:852-3.
13. Lemaire G, Terouanne B, Mauvais P, Michel S, Rahmani R. Effect of organochlorine pesticides on human androgen receptor activation in vitro. Toxicol Appl Pharmacol 2004;196:235-46.
14. Roy P, Salminen H, Koskimies P, Simola J, Smeds A, Saukko P, et al. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J Steroid Biochem Mol Biol 2004;88:157-66.
15. Paris F, Servant N, Terouanne B, Sultan C. Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results. Mol Cell Endocrinol 2002;198:123-9.
16. Blankvoort BM, de Groene EM, van Meeteren-Kreikamp AP, Witkamp RF, Rodenburg RJ, Aarts JM. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. Anal Biochem 2001;298:93-102.